Wilbanks Smith & Thomas Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,291
Closed -$462K 399
2020
Q2
$462K Buy
5,291
+270
+5% +$23.3K 0.03% 250
2020
Q1
$414K Sell
5,021
-973
-16% -$86.8K 0.03% 243
2019
Q4
$568K Buy
5,994
+398
+7% +$35.7K 0.03% 232
2019
Q3
$486K Sell
5,596
-842
-13% -$75.6K 0.03% 234
2019
Q2
$588K Sell
6,438
-930
-13% -$78.7K 0.04% 207
2019
Q1
$635K Buy
7,368
+472
+7% +$37.9K 0.04% 210
2018
Q4
$530K Sell
6,896
-1,345
-16% -$105K 0.04% 200
2018
Q3
$636K Buy
8,241
+1,332
+19% +$98.5K 0.04% 206
2018
Q2
$468K Sell
6,909
-47
-0.7% -$3.24K 0.04% 207
2018
Q1
$504K Sell
6,956
-35
-0.5% -$2.66K 0.04% 189
2017
Q4
$526K Sell
6,991
-167
-2% -$12.6K 0.04% 190
2017
Q3
$551K Buy
7,158
+157
+2% +$11.9K 0.05% 185
2017
Q2
$524K Sell
7,001
-122
-2% -$8.65K 0.05% 180
2017
Q1
$474K Sell
7,123
-135
-2% -$9K 0.04% 181
2016
Q4
$474K Buy
7,258
+1,116
+18% +$72.4K 0.04% 171
2016
Q3
$435K Buy
6,142
+1,124
+22% +$81.9K 0.04% 175
2016
Q2
$371K Buy
5,018
+130
+3% +$8.98K 0.04% 193
2016
Q1
$317K Buy
4,888
+1,627
+50% +$111K 0.04% 214
2015
Q4
$251K Sell
3,261
-75
-2% -$5.96K 0.02% 234
2015
Q3
$275K Buy
3,336
+289
+9% +$25.7K 0.04% 210
2015
Q2
$268K Buy
3,047
+177
+6% +$16.2K 0.03% 250
2015
Q1
$254K Sell
2,870
-148
-5% -$13.1K 0.03% 259
2014
Q4
$251K Sell
3,018
-18
-0.6% -$1.49K 0.03% 256
2014
Q3
$256K Buy
3,036
+341
+13% +$27.6K 0.03% 240
2014
Q2
$219K Sell
2,695
-163
-6% -$12.8K 0.02% 264
2014
Q1
$218K Buy
+2,858
New +$208K 0.02% 255
2013
Q4
Sell
-8,228
Closed -$566K 293
2013
Q3
$566K Buy
8,228
+1,084
+15% +$71.7K 0.08% 150
2013
Q2
$453K Buy
+7,144
New +$465K 0.07% 160

Other funds holding NVS